Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations:  Abbvie, Adverum, Avenue, Basilea, Biosyngen, Gamida, Huidagene, Hutchmed, Hyloris, Madrigal.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Direct, Everest, Finch, Keyuan Xinhua, Maxion, Nona, Shanghai, Sinopia.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Alzamend, Alzheon, Anixa, Arch, Autobahn, Biolinerx, Clearside, FSD, Lisata, Madrigal, Merus, Nova Mentis, Plus, Renovion, Sellas, Technoderma.

Biopharmas raising money in public or private financings, including: Allarity, Forbion, Gamida, Inflarx, Phio, Satellos, TME, Vaxcyte.

New hires and promotions in the biopharma industry, including: Agios, Astria, Cardurion, Engimmune, Keros, Lytix, Maplight, NRG.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Foresee.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Biosyngen, Boan, Bone, Junshi, JW, Minghui, Nicox, Ocumension, Takeda, Telix.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Adaptive, Eisai, Genequantum Healthcare, Geovax Labs, Gilead Sciences, Pyramid, Takeda, Tiziana Life Sciences, Treventis.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Astellas, Atea, Bridge, Eisai, Genexine, Gilead Sciences, Junshi, Mabwell, Merck, Minghui, Moderna, Nuance, Zenshine.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Femasys, Hemovent, Masimo, Neuspera, Rapidai, Syantra.